Structure-function relationships of the N-terminus of receptor activity-modifying proteins

被引:33
|
作者
Qi, Tao [1 ]
Hay, Debbie L. [1 ]
机构
[1] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand
关键词
receptor activity-modifying proteins; calcitonin receptor; calcitonin receptor-like receptor; calcitonin; calcitonin gene-related peptide; adrenomedullin; amylin; mutagenesis; GENE-RELATED PEPTIDE; DIFFERENTIALLY MODULATE; AGONIST BINDING; RAMP DOMAINS; ADRENOMEDULLIN; AMYLIN; RESIDUES; GLYCOSYLATION; INTERNALIZATION; IDENTIFICATION;
D O I
10.1111/j.1476-5381.2009.00541.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The receptor activity-modifying proteins (RAMPs) are a family of three single transmembrane proteins that have been identified as accessory proteins to some G-protein-coupled receptors (GPCRs). They can regulate their pharmacology, forward trafficking and recycling, depending on the GPCR. The best characterized receptor complexes formed by RAMPs and GPCRs are the calcitonin peptide family receptors. The association of RAMP1 with the calcitonin receptor-like receptor (CL) constitutes the calcitonin gene-related peptide receptor, whereas RAMP2 or 3 with CL generates adrenomedullin receptors. In this case, the RAMPs substantially alter the pharmacology and trafficking properties of this GPCR. Amylin receptor subtypes are formed from calcitonin receptor (CTR) interactions with RAMPs. Although the RAMPs themselves are not responsive to calcitonin peptide family ligands, there is clear evidence that they participate in ligand binding, although it is still unclear whether this is by directly participating in binding or through allosteric modulation of CL or CTR. A considerable amount of mutagenesis data have now been generated on RAMPs to try and identify the residues that play a role in ligand interactions, and to also identify which residues in RAMPs interact with CL and CTR. This review will focus on RAMP mutagenesis studies with CL, summarizing and discussing the available data in association with current RAMP models and structures. The data reveal key regions in RAMPs that are important for ligand binding and receptor interactions. British Journal of Pharmacology (2010) 159, 1059-1068; doi: 10.1111/j.1476-5381.2009.00541.x; published online 10 December 2009
引用
收藏
页码:1059 / 1068
页数:10
相关论文
共 50 条
  • [1] Novel receptor partners and function of receptor activity-modifying proteins
    Christopoulos, A
    Christopoulos, G
    Morfis, M
    Udawela, M
    Laburthe, M
    Couvineau, A
    Kuwasako, K
    Tilakaratne, N
    Sexton, PM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) : 3293 - 3297
  • [2] A critical role for the short intracellular C terminus in receptor activity-modifying protein function
    Udawela, Madhara
    Christopoulos, George
    Morfis, Maria
    Christopoulos, Arthur
    Ye, Siying
    Tilakaratne, Nanda
    Sexton, Patrick M.
    MOLECULAR PHARMACOLOGY, 2006, 70 (05) : 1750 - 1760
  • [3] A Deep Dive into the N-Terminus of STIM Proteins: Structure-Function Analysis and Evolutionary Significance of the Functional Domains
    Narayanasamy, Sasirekha
    Ong, Hwei Ling
    Ambudkar, Indu S.
    BIOMOLECULES, 2024, 14 (10)
  • [4] The N-terminus of hepcidin is essential for its interaction with ferroportin: Structure-function study
    Preza, GC
    Nemeth, E
    Waring, AJ
    Ganz, T
    FASEB JOURNAL, 2006, 20 (05): : A1276 - A1276
  • [5] The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study
    Nemeth, E
    Preza, GC
    Jung, CL
    Kaplan, J
    Waring, AJ
    Ganz, T
    BLOOD, 2006, 107 (01) : 328 - 333
  • [6] The N-terminus of hepcidin is essential for its interaction with ferroportin: Structure-function study
    Nemeth, E
    Preza, GC
    Waring, AJ
    Ganz, T
    BLOOD, 2005, 106 (11) : 1000A - 1000A
  • [7] Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking
    Bomberger, JM
    Parameswaran, N
    Hall, CS
    Aiyar, N
    Spielman, WS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (10) : 9297 - 9307
  • [8] The role of receptor activity-modifying proteins in obesity and diabetes mellitus
    Malcharek, Milena A.
    Pearce, Abigail
    Brighton, Cheryl A.
    Hornigold, David C.
    Ladds, Graham
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2024, 73 (04)
  • [9] The CGRP receptor subtypes associated with receptor activity-modifying proteins (RAMPs)
    Kuwasako, K
    Cao, YN
    Nagoshi, Y
    Kitamura, K
    Eto, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 98P - 98P
  • [10] Multiplexed mapping of the interactome of GPCRs with receptor activity-modifying proteins
    Kotliar, Ilana B.
    Bendes, Annika
    Dahl, Leo
    Chen, Yuanhuang
    Saarinen, Marcus
    Ceraudo, Emilie
    Dodig-Crnkovic, Tea
    Uhlen, Mathias
    Svenningsson, Per
    Schwenk, Jochen M.
    Sakmar, Thomas P.
    SCIENCE ADVANCES, 2024, 10 (31):